Live Breaking News & Updates on Gen Pharma Ltd|Page 1

Stay updated with breaking news from Gen pharma ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UroGen Pharma (NASDAQ:URGN) PT Lowered to $32.00 at Oppenheimer

UroGen Pharma (NASDAQ:URGN – Free Report) had its price target cut by Oppenheimer from $34.00 to $32.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have an outperform rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $54.00 target price on shares of UroGen Pharma […] ....

Urogen Pharma , Mark Schoenberg , Urogen Pharma Ltd , Connor Clark Lunn Investment Management Ltd , China Universal Asset Management Co , Allspring Global Investments Holdings , Jump Financial , Securities Exchange Commission , Free Report , Gen Pharma Trading Down , Gen Pharma , Get Free Report , Exchange Commission , Global Investments Holdings , Universal Asset Management , Financial Markets , Connor Clark , Lunn Investment Management , Gen Pharma Ltd , Urogen Pharma Daily ,

UroGen Pharma's (URGN) "Buy" Rating Reiterated at HC Wainwright

UroGen Pharma's (URGN) "Buy" Rating Reiterated at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Urogen Pharma , Mark Schoenberg , Urogen Pharma Company Profile , Hermes Inc , Allspring Global Investments Holdings , Sg Americas Securities , Sierra Summit Advisors , China Universal Asset Management Co , Urogen Pharma Ltd , Free Report , Gen Pharma Trading Down , Gen Pharma , Get Free Report , Universal Asset Management , Global Investments Holdings , Gen Pharma Ltd , Urogen Pharma Daily ,